Nezeril nasal spray

Nezeril is a well-known nasal decongestant widely used in the Nordic regions, particularly Sweden. It was originally developed by the Swedish pharmaceutical company Astra (later AstraZeneca) and gained popularity for its effectiveness in treating nasal congestion due to colds or allergies.

Over the years, the brand has transitioned through various corporate restructurings within the pharmaceutical industry. Following its time under AstraZeneca, the brand was part of Meda AB, a Swedish specialty pharma company. Today, Nezeril is owned by Viatris Inc., a global healthcare company formed through the merger of Mylan and Pfizer's Upjohn division. While the brand has deep heritage in Swedish pharmacy history, it is now managed as part of a large international portfolio of consumer healthcare products.